USD $162.00
Daklinza, with the active ingredient Daclatasvir, is a medication used to treat chronic hepatitis C virus (HCV) infection in adults. It is typically prescribed as part of a combination antiviral treatment regimen. Each package contains 28 tablets, with each tablet containing 60mg of Daclatasvir.
Daklinza works by inhibiting the NS5A protein, which is essential for the replication of the hepatitis C virus. By blocking this protein, Daklinza helps to prevent the virus from multiplying, thereby reducing the viral load in the body. This action aids in clearing the infection from the bloodstream when used in combination with other antiviral medications.
Daklinza is prescribed for adults diagnosed with chronic hepatitis C. The suitability and specific treatment regimen should be determined by a healthcare professional, based on the patient's medical history and the specific genotype of the hepatitis C virus.
The recommended dosage of Daklinza is 60mg once daily, taken orally with or without food. It is important to follow the healthcare provider's instructions and complete the full course of treatment as prescribed. Consistency in taking the medication at the same time each day is advised to maintain optimal therapeutic levels.
Common side effects of Daklinza may include headache, fatigue, and nausea. Patients are advised to contact their healthcare provider if they experience any severe or persistent side effects. Monitoring by a healthcare professional is recommended to manage any adverse reactions.
Daklinza is often used in combination with other antiviral medications to enhance its effectiveness. However, it is essential to inform the healthcare provider of all medications currently being taken, including over-the-counter drugs and supplements, to avoid potential drug interactions.
Patients should inform their healthcare provider of their complete medical history, including any liver problems or other health conditions. Pregnant or breastfeeding women should discuss potential risks and benefits with their healthcare provider. Regular follow-up appointments are recommended to monitor the treatment's progress.
Store Daklinza tablets in a cool, dry place away from direct sunlight and moisture. Keep the medication out of reach of children and pets. Do not use the medication past the expiration date indicated on the packaging.
Health Guides